Related Experiment Video
Updated: Apr 29, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities
Radhika Nair1, Wee Siang Teo1, Vivek Mittal2
1Cancer Research Division & Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, New South Wales, Australia.
Abstract:
The inhibitor of differentiation (ID) proteins are helix-loop-helix transcriptional repressors with established roles in stem cell self-renewal, lineage commitment, and niche interactions. While deregulated expression of ID proteins in cancer was identified more than a decade ago, emerging evidence has revealed a central role for ID proteins in neoplastic progression of multiple tumor types that often mirrors their function in physiological stem and progenitor cells. ID proteins are required for the maintenance of cancer stem cells, self-renewal, and proliferation in a range of malignancies. Furthermore, ID proteins promote metastatic dissemination through their role in remodeling the tumor microenvironment and by promoting tumor-associated endothelial progenitor cell proliferation and mobilization. Here, we discuss the latest findings in this area and the clinical opportunities that they provide.
Insights
Inhibitor of differentiation (ID) proteins are crucial for cancer stem cell maintenance and tumor progression. Targeting these proteins offers new clinical opportunities for treating various malignancies.
Area of Science:
- Molecular Biology
- Cancer Research
- Stem Cell Biology
Background:
- Inhibitor of differentiation (ID) proteins are helix-loop-helix transcriptional repressors.
- ID proteins regulate stem cell self-renewal, lineage commitment, and niche interactions.
- Deregulated ID protein expression is linked to cancer development.
Purpose of the Study:
- To review the latest findings on the role of ID proteins in neoplastic progression.
- To discuss the clinical opportunities presented by targeting ID proteins in cancer.
- To highlight the parallels between ID protein functions in physiological stem cells and cancer.
Main Methods:
- Literature review of recent research on ID proteins in cancer.
- Analysis of ID protein functions in cancer stem cell maintenance, proliferation, and metastasis.
- Exploration of ID protein roles in tumor microenvironment remodeling and endothelial progenitor cell activity.
Main Results:
- ID proteins are essential for cancer stem cell self-renewal and proliferation across various malignancies.
- ID proteins contribute to metastatic dissemination by influencing the tumor microenvironment.
- ID proteins promote the proliferation and mobilization of tumor-associated endothelial progenitor cells.
Conclusions:
- ID proteins play a central role in neoplastic progression, mirroring their functions in normal stem cells.
- Targeting ID proteins presents promising clinical strategies for cancer therapy.
- Further research into ID protein functions can unlock new therapeutic avenues.
More Related Videos
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Mitogens and the Cell Cycle